Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Derivation and Validation of the Risk Evaluation Score for Pneumonia Involving Resistant Entities (RESPIRE)

NCT07425561 is registered in ClinicalTrials.gov with Azienda Ospedaliero-Universitaria Careggi as lead sponsor.

NCT NCT07425561
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07425561 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Derivation and Validation of the Risk Evaluation Score for Pneumonia Involving Resistant Entities (RESPIRE)
Lead sponsor
Azienda Ospedaliero-Universitaria Careggi
Phase
Observational
Overall status
Completed
Start date
January 1, 2022
Completion date
February 8, 2026
Enrollment
300 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

community acquired pneumonia, community acquired pneumonia (cap), community acquired pneumonia, severe, emergency, multi drug resistant, multi drug resistant organisms, pneumonia, pneumonia - bacterial